Nano-imaging agents for brain diseases: Environmentally responsive imaging and therapy

Jansen, I. G. H.; Berkhemer, O. A.; Yoo, A. J.; Vos, J. A.; Lycklama, A. N. G. J.; Sprengers, M. E. S.; van Zwam, W. H.; Schonewille, W. J.; Boiten, J.; van Walderveen, M. A. A. et al. Comparison of CTA- and DSA-based collateral flow assessment in patients with anterior circulation stroke. AJNR Am. J. Neuroradiol. 2016, 37, 2037–2042.

Czap, A. L.; Sheth, S. A. Overview of imaging modalities in stroke. Neurology 2021, 97, S42–S51.

Terstappen, G. C.; Meyer, A. H.; Bell, R. D.; Zhang, W. D. Strategies for delivering therapeutics across the blood-brain barrier. Nat. Rev. Drug Discov. 2021, 20, 362–383.

Dube, T.; Kumar, N.; Bishnoi, M.; Panda, J. J. Dual blood-brain barrier-glioma targeting peptide-poly(levodopamine) hybrid nanoplatforms as potential near infrared phototheranostic agents in glioblastoma. Bioconjug. Chem. 2021, 32, 2014–2031.

Kim, H. S.; Seo, M.; Park, T. E.; Lee, D. Y. A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy. J. Nanobiotechnology 2022, 20, 14.

Zhu, M. T.; Sheng, Z. H.; Jia, Y. L.; Hu, D. H.; Liu, X.; Xia, X. Y.; Liu, C. B.; Wang, P.; Wang, X. B.; Zheng, H. R. Indocyanine green-holo-transferrin nanoassemblies for tumor-targeted dual-modal imaging and photothermal therapy of glioma. ACS Appl. Mater. Interfaces 2017, 9, 39249–39258.

Dube, T.; Kompella, U. B.; Panda, J. J. Near infrared triggered chemo-PTT-PDT effect mediated by glioma directed twin functional-chimeric peptide-decorated gold nanoroses. J. Photochem. Photobiol. B 2022, 228, 112407.

Wan, Q.; Zou, C.; Hu, D. H.; Zhou, J.; Chen, M. J.; Tie, C. J.; Qiao, Y. Z.; Yan, F.; Cheng, C. L.; Sheng, Z. H. et al. Imaging-guided focused ultrasound-induced thermal and sonodynamic effects of nanosonosensitizers for synergistic enhancement of glioblastoma therapy. Biomater. Sci. 2019, 7, 3007–3015.

Miao, J.; Miao, M. Q.; Jiang, Y.; Zhao, M.; Li, Q.; Zhang, Y.; An, Y.; Pu, K. Y.; Miao, Q. Q. An activatable NIR-II fluorescent reporter for in vivo imaging of Amyloid-β plaques. Angew. Chem., Int. Ed. 2023, 62, e202216351.

Elbatrawy, A. A.; Hyeon, S. J.; Yue, N.; Osman, E. E. A.; Choi, S. H.; Lim, S.; Kim, Y. K.; Ryu, H.; Cui, M. C.; Nam, G. “Turn-on” quinoline-based fluorescent probe for selective imaging of tau aggregates in Alzheimer’s disease: Rational design, synthesis, and molecular docking. ACS Sens. 2021, 6, 2281–2289.

Su, J.; Yao, Z. P.; Chen, Z. X.; Zhou, S. S.; Wang, Z.; Xia, H. P.; Liu, S. Q.; Wu, Y. F. TfR Aptamer enhanced blood-brain barrier penetration of biomimetic nanocomplexes for intracellular transglutaminase 2 imaging and silencing in glioma. Small 2022, 18, 2203448.

Deng, G. J.; Peng, X. H.; Sun, Z. H.; Zheng, W.; Yu, J.; Du, L. L.; Chen, H. J.; Gong, P.; Zhang, P. F.; Cai, L. T. et al. Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics. ACS Nano 2020, 14, 11452–11462.

Chen, S. Y.; Miao, H.; Jiang, X. Y.; Sun, P. F.; Fan, Q. L.; Huang, W. Starlike polymer brush-based ultrasmall nanoparticles with simultaneously improved NIR-II fluorescence and blood circulation for efficient orthotopic glioblastoma imaging. Biomaterials 2021, 275, 120916.

Jiang, Y. Y.; Upputuri, P. K.; Xie, C.; Lyu, Y.; Zhang, L. L.; Xiong, Q. H.; Pramanik, M.; Pu, K. Y. Broadband absorbing semiconducting polymer nanoparticles for photoacoustic imaging in second near-infrared window. Nano Lett. 2017, 17, 4964–4969.

Jia, G.; Han, Y.; An, Y. L.; Ding, Y. N.; He, C.; Wang, X. H.; Tang, Q. S. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials 2018, 178, 302–316.

Liu, X. G.; Zhang, L.; Lu, S.; Liu, D. Q.; Zhang, L. X.; Yu, X. L.; Liu, R. T. Multifunctional superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class a scavenger receptor activator show early diagnostic potentials for Alzheimer’s disease. Int. J. Nanomedicine 2020, 15, 4919–4932.

Tang, C. M.; Wang, C.; Zhang, Y.; Xue, L. J.; Li, Y. Y.; Ju, C. Y.; Zhang, C. Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke. Nano Lett. 2019, 19, 4470–4477.

Mishra, S. K.; Khushu, S.; Singh, A. K.; Gangenahalli, G. Homing and tracking of iron oxide labelled mesenchymal stem cells after infusion in traumatic brain injury mice: A longitudinal in vivo MRI study. Stem Cell Rev. Rep. 2018, 14, 888–900.

Xu, H. L.; Yang, J. J.; ZhuGe, D. L.; Lin, M. T.; Zhu, Q. Y.; Jin, B. H.; Tong, M. Q.; Shen, B. X.; Xiao, J.; Zhao, Y. Z. Glioma-targeted delivery of a theranostic liposome integrated with quantum dots, superparamagnetic iron oxide, and cilengitide for dual-imaging guiding cancer surgery. Adv. Healthc. Mater. 2018, 7, 1701130.

Zhang, J.; Chen, N.; Wang, H.; Gu, W.; Liu, K.; Ai, P. H.; Yan, C. X.; Ye, L. Dual-targeting superparamagnetic iron oxide nanoprobes with high and low target density for brain glioma imaging. J. Colloid Interface Sci. 2016, 469, 86–92.

Wang, H.; Mu, Q. X.; Revia, R.; Wang, K.; Tian, B. W.; Lin, G. Y.; Lee, W.; Hong, Y. K.; Zhang, M. Q. Iron oxide-carbon core–shell nanoparticles for dual-modal imaging-guided photothermal therapy. J. Control. Release 2018, 289, 70–78.

Richard, S.; Saric, A.; Boucher, M.; Slomianny, C.; Geffroy, F.; Mériaux, S.; Lalatonne, Y.; Petit, P. X.; Motte, L. Antioxidative theranostic iron oxide nanoparticles toward brain tumors imaging and ROS production. ACS Chem. Biol. 2016, 11, 2812–2819.

Sukumar, U. K.; Bose, R. J. C.; Malhotra, M.; Babikir, H. A.; Afjei, R.; Robinson, E.; Zeng, Y. T.; Chang, E.; Habte, F.; Sinclair, R. et al. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials 2019, 218, 119342.

Liu, H.; Chen, X.; Xue, W.; Chu, C. C.; Liu, Y.; Tong, H. P.; Du, X. S.; Xie, T.; Liu, G.; Zhang, W. G. Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging. Int. J. Nanomedicine 2016, 11, 5099–5108.

Meng, X. X.; Wan, J. Q.; Jing, M.; Zhao, S. G.; Cai, W.; Liu, E. Z. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents. Acta Pharmacol. Sin. 2007, 28, 2019–2026.

Karimian-Jazi, K.; Münch, P.; Alexander, A.; Fischer, M.; Pfleiderer, K.; Piechutta, M.; Karreman, M. A.; Solecki, G. M.; Berghoff, A. S.; Friedrich, M. et al. Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM). Theranostics 2020, 10, 1873–1883.

Bernal, G. M.; LaRiviere, M. J.; Mansour, N.; Pytel, P.; Cahill, K. E.; Voce, D. J.; Kang, S. J.; Spretz, R.; Welp, U.; Noriega, S. E. et al. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 2014, 10, 149–157.

Lei, H. L.; Nan, X.; Wang, Z. Y.; Gao, L.; Xie, L. S.; Zou, C.; Wan, Q.; Pan, D.; Beauchamp, N.; Yang, X. M. et al. Stem cell labeling with superparamagnetic iron oxide nanoparticles using focused ultrasound and magnetic resonance imaging tracking. J. Nanosci. Nanotechnol. 2015, 15, 2605–2612.

Liu, H. R.; Sun, R.; Wang, L.; Chen, X. Y.; Li, G. L.; Cheng, Y.; Zhai, G. H.; Bay, B. H.; Yang, F.; Gu, N. et al. Biocompatible iron oxide nanoring-labeled mesenchymal stem cells: An innovative magnetothermal approach for cell tracking and targeted stroke therapy. ACS Nano 2022, 16, 18806–18821.

Pan, Y. B.; Wang, S. Q.; He, X. C.; Tang, W. W.; Wang, J. H.; Shao, A. W.; Zhang, J. M. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles. J. Mater. Chem. B 2019, 7, 7683–7689.

Sun, D.; Liu, K. J.; Li, Y.; Xie, T.; Zhang, M.; Liu, Y.; Tong, H. P.; Guo, Y.; Zhang, Q. H.; Liu, H. et al. Intrinsically bioactive manganese-eumelanin nanocomposites mediated antioxidation and anti-neuroinflammation for targeted theranostics of traumatic brain injury. Adv. Healthc. Mater. 2022, 11, 2200517.

Zhao, Q. Q.; Du, W. X.; Zhou, L. L.; Wu, J. R.; Zhang, X. X.; Wei, X. E.; Wang, S. J.; Huang, Y.; Li, Y. H. Transferrin-enabled blood-brain barrier crossing manganese-based nanozyme for rebalancing the reactive oxygen species level in ischemic stroke. Pharmaceutics 2022, 14, 1122.

Terry, A. V. Jr.; Beck, W. D.; Lin, P. C.; Callahan, P. M.; Rudic, R. D.; Hamrick, M. W. Manganese-enhanced magnetic resonance imaging method detects age-related impairments in axonal transport in mice and attenuation of the impairments by a microtubule-stabilizing compound. Brain Res. 2022, 1789, 147947.

Hou, W. J.; Jiang, Y. Z.; Xie, G. C.; Zhao, L.; Zhao, F. S.; Zhang, X. J.; Sun, S. K.; Yu, C. S.; Pan, J. B. Biocompatible BSA-MnO₂ nanoparticles for in vivo timely permeability imaging of blood-brain barrier and prediction of hemorrhage transformation in acute ischemic stroke. Nanoscale 2021, 13, 8531–8542.

Xiao, T. T.; He, M. J.; Xu, F.; Fan, Y.; Jia, B. Y.; Shen, M. W.; Wang, H.; Shi, X. Y. Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy/chemodynamic therapy of orthotopic glioma. ACS Nano 2021, 15, 20377–20390.

Jiang, S. Q.; Li, X. H.; Zhang, F.; Mao, J. J.; Cao, M. H.; Zhang, X. N.; Huang, S. M.; Duan, X. H.; Shen, J. Manganese dioxide-based nanocarrier delivers paclitaxel to enhance chemotherapy against orthotopic glioma through hypoxia relief. Small Methods 2022, 6, 2101531.

Lai, J. X.; Wang, T. J.; Wang, H.; Shi, F. Q.; Gu, W.; Ye, L. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma. Mikrochim. Acta 2018, 185, 244.

Tan, J. Y.; Duan, X. H.; Zhang, F.; Ban, X. H.; Mao, J. J.; Cao, M. H.; Han, S. S.; Shuai, X. T.; Shen, J. Theranostic nanomedicine for synergistic chemodynamic therapy and chemotherapy of orthotopic glioma. Adv. Sci. 2020, 7, 2003036.

Wang, R. N.; Zhang, X. R.; Huang, J. Y.; Feng, K. H.; Zhang, Y. J.; Wu, J.; Ma, L.; Zhu, A. R.; Di, L. Q. Bio-fabricated nanodrugs with chemo-immunotherapy to inhibit glioma proliferation and recurrence. J. Control. Release 2023, 354, 572–587.

Xu, K.; Zhao, Z. H.; Zhang, J. F.; Xue, W.; Tong, H. P.; Liu, H.; Zhang, W. G. Albumin-stabilized manganese-based nanocomposites with sensitive tumor microenvironment responsivity and their application for efficient siRNA delivery in brain tumors. J. Mater. Chem. B 2020, 8, 1507–1515.

Liang, K. C.; Li, Z. C.; Luo, Y.; Zhang, Q. H.; Yin, F. F.; Xu, L. J.; Chen, H. R.; Wang, H. Intelligent nanocomposites with intrinsic blood-brain-barrier crossing ability designed for highly specific MR imaging and sonodynamic therapy of glioblastoma. Small 2020, 16, 1906985.

Liu, H. M.; Zhou, M. J.; Sheng, Z. H.; Chen, Y.; Yeh, C. K.; Chen, W. T.; Liu, J.; Liu, X.; Yan, F.; Zheng, H. R. Theranostic nanosensitizers for highly efficient MR/fluorescence imaging-guided sonodynamic therapy of gliomas. J. Cell. Mol. Med. 2018, 22, 5394–5405.

Qin, R. X.; Li, S.; Qiu, Y. W.; Feng, Y. S.; Liu, Y. Q.; Ding, D. D.; Xu, L. H.; Ma, X. Q.; Sun, W. J.; Chen, H. M. Carbonized paramagnetic complexes of Mn(II) as contrast agents for precise magnetic resonance imaging of sub-millimeter-sized orthotopic tumors. Nat. Commun. 2022, 13, 1938.

Chen, N.; Shao, C.; Li, S.; Wang, Z. H.; Qu, Y. M.; Gu, W.; Yu, C. J.; Ye, L. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas. J. Colloid Interface Sci. 2015, 457, 27–34.

Rodriguez, O.; Schaefer, M. L.; Wester, B.; Lee, Y. C.; Boggs, N.; Conner, H. A.; Merkle, A. C.; Fricke, S. T.; Albanese, C.; Koliatsos, V. E. Manganese-enhanced magnetic resonance imaging as a diagnostic and dispositional tool after mild-moderate blast traumatic brain injury. J. Neurotrauma 2016, 33, 662–671.

Song, G. R.; Zhang, B. R.; Song, L. Y.; Li, W. Z.; Liu, C. X.; Chen, L. S.; Liu, A. H. MnCO₃@BSA-ICG nanoparticles as a magnetic resonance/photoacoustic dual-modal contrast agent for functional imaging of acute ischemic stroke. Biochem. Biophys. Res. Commun. 2022, 614, 125–131.

Kim, J. H.; Ha, T. L.; Im, G. H.; Yang, J.; Seo, S. W.; Lee, I. S.; Lee, J. H. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody Aβ1-40 in a transgenic mouse model. Neuroreport 2013, 24, 16–21.

Zhang, L. R.; Chen, D. Y.; Zhang, J. J.; Cai, R.; Xu, L. X.; Yu, N. H.; Zhang, S. Y.; Yan, H.; Jiang, J. Z.; Du, F. Y. et al. A novel cholchicine/gadolinium-loading tubulin self-assembly nanocarrier for MR imaging and chemotherapy of glioma. Nanotechnology 2020, 31, 255601.

Shen, Z. Y.; Liu, T.; Yang, Z.; Zhou, Z. J.; Tang, W.; Fan, W. P.; Liu, Y. J.; Mu, J.; Li, L.; Bregadze, V. I. et al. Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma. Biomaterials 2020, 235, 119783.

Zhang, H.; Wang, T. J.; Zheng, Y. Y.; Yan, C. X.; Gu, W.; Ye, L. Comparative toxicity and contrast enhancing assessments of Gd₂O₃@BSA and MnO₂@BSA nanoparticles for MR imaging of brain glioma. Biochem. Biophys. Res. Commun. 2018, 499, 488–492.

Bony, B. A.; Miller, H. A.; Tarudji, A. W.; Gee, C. C.; Sarella, A.; Nichols, M. G.; Kievit, F. M. Ultrasmall mixed Eu-Gd oxide nanoparticles for multimodal fluorescence and magnetic resonance imaging of passive accumulation and retention in TBI. ACS Omega 2020, 5, 16220–16227.

Hubert, V.; Hristovska, I.; Karpati, S.; Benkeder, S.; Dey, A.; Dumot, C.; Amaz, C.; Chounlamountri, N.; Watrin, C.; Comte, J. C. et al. Multimodal imaging with NanoGd reveals spatiotemporal features of neuroinflammation after experimental stroke. Adv. Sci. 2021, 8, 2101433.

Wang, X. L.; Chan, H. N.; Desbois, N.; Gros, C. P.; Bolze, F.; Li, Y. H.; Li, H. W.; Wong, M. S. Multimodal theranostic cyanine-conjugated gadolinium(III) complex for in vivo imaging of amyloid-β in an Alzheimer’s disease mouse model. ACS Appl. Mater. Interfaces 2021, 13, 18525–18532.

Zhang, X. H.; Ye, D. Z.; Yang, L. H.; Yue, Y. M.; Sultan, D.; Pacia, C. P.; Pang, H.; Detering, L.; Heo, G. S.; Luehmann, H. et al. Magnetic resonance imaging-guided focused ultrasound-based delivery of radiolabeled copper nanoclusters to diffuse intrinsic pontine glioma. ACS Appl. Nano. Mater. 2020, 3, 11129–11134.

Shi, X. D.; Shen, L. T. Integrin α_vβ₃ receptor targeting PET/MRI dual-modal imaging probe based on the ⁶⁴Cu labeled manganese ferrite nanoparticles. J. Inorg. Biochem. 2018, 186, 257–263.

Liu, Y. J.; Yang, Z.; Huang, X. L.; Yu, G. C.; Wang, S.; Zhou, Z. J.; Shen, Z. Y.; Fan, W. P.; Liu, Y.; Davisson, M. et al. Glutathione-responsive self-assembled magnetic gold nanowreath for enhanced tumor imaging and imaging-guided photothermal therapy. ACS Nano 2018, 12, 8129–8137.

Gao, X.; Pan, H. J.; Han, Y. C.; Feng, L. X.; Xiong, J. P.; Luo, S. Z.; Li, H. M. Quantitative imaging of amyloid beta peptide (Aβ) in Alzheimer’s brain tissue by laser ablation ICP-MS using gold nanoparticles as labels. Anal. Chim. Acta 2021, 1148, 238197.

Chan, M. H.; Chen, W.; Li, C. H.; Fang, C. Y.; Chang, Y. C.; Wei, D. H.; Liu, R. S.; Hsiao, M. An advanced in situ magnetic resonance imaging and ultrasonic theranostics nanocomposite platform: Crossing the blood-brain barrier and improving the suppression of glioblastoma using iron-platinum nanoparticles in nanobubbles. ACS Appl. Mater. Interfaces 2021, 13, 26759–26769.

Zhao, L. Z.; Li, Y. J.; Zhu, J. Y.; Sun, N.; Song, N. N.; Xing, Y.; Huang, H.; Zhao, J. H. Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT/CT imaging and radionuclide therapy. J. Nanobiotechnology 2019, 17, 30.

Chen, M.; Zhang, L.; Gao, M. X.; Zhang, X. M. High-sensitive bioorthogonal SERS tag for live cancer cell imaging by self-assembling core-satellites structure gold-silver nanocomposite. Talanta 2017, 172, 176–181.

Basu, S. S.; McMinn, M. H.; Gimenéz-Cassina Lopéz, B.; Regan, M. S.; Randall, E. C.; Clark, A. R.; Cox, C. R.; Agar, N. Y. R. Metal oxide laser ionization mass spectrometry imaging (MOLI MSI) using cerium(IV) oxide. Anal. Chem. 2019, 91, 6800–6807.

Shao, C.; Li, S.; Gu, W.; Gong, N. Q.; Zhang, J.; Chen, N.; Shi, X. Y.; Ye, L. Multifunctional gadolinium-doped manganese carbonate nanoparticles for targeted MR/fluorescence imaging of tiny brain gliomas. Anal. Chem. 2015, 87, 6251–6257.

Li, J.; Kong, J. L.; Ma, S. H.; Li, J. C.; Mao, M. R.; Chen, Z. T.; Zhang, J. X.; Chang, Y. N.; Yuan, H.; Liu, T. et al. Exosome-coated ¹⁰B carbon dots for precise boron neutron capture therapy in a mouse model of glioma in situ. Adv. Funct. Mater. 2021, 31, 2100969.

Tak, K.; Sharma, R.; Dave, V.; Jain, S.; Sharma, S. Clitoria ternatea mediated synthesis of graphene quantum dots for the treatment of Alzheimer’s disease. ACS Chem. Neurosci. 2020, 11, 3741–3748.

Chen, C. Q.; Cai, Q.; Luo, F.; Dong, N.; Guo, L. H.; Qiu, B.; Lin, Z. Y. Sensitive fluorescent sensor for hydrogen sulfide in rat brain microdialysis via CsPbBr₃ quantum dots. Anal. Chem. 2019, 91, 15915–15921.

Huang, D. H.; Cao, Y. H.; Yang, X.; Liu, Y. Y.; Zhang, Y. J.; Li, C. Y.; Chen, G. C.; Wang, Q. B. A nanoformulation-mediated multifunctional stem cell therapy with improved beta-amyloid clearance and neural regeneration for Alzheimer’s disease. Adv. Mater. 2021, 33, 2006357.

Song, D.; Zhu, M. T.; Chi, S. Y.; Xia, L.; Li, Z.; Liu, Z. H. Sensitizing the luminescence of lanthanide-doped nanoparticles over 1500 nm for high-contrast and deep imaging of brain injury. Anal. Chem. 2021, 93, 7949–7957.

Ag Seleci, D.; Maurer, V.; Barlas, F. B.; Porsiel, J. C.; Temel, B.; Ceylan, E.; Timur, S.; Stahl, F.; Scheper, T.; Garnweitner, G. Transferrin-decorated niosomes with integrated InP/ZnS quantum dots and magnetic iron oxide nanoparticles: Dual targeting and imaging of glioma. Int. J. Mol. Sci. 2021, 22, 4556.

Lv, Z. J.; Jin, L. H.; Cao, Y.; Zhang, H.; Xue, D. Z.; Yin, N.; Zhang, T. Q.; Wang, Y. H.; Liu, J. H.; Liu, X. G. et al. A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-II fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma. Light Sci. Appl. 2022, 11, 116.

Liu, Z.; Yun, B. F.; Han, Y. B.; Jiang, Z. L.; Zhu, H. Q.; Ren, F.; Li, Z. Dye-sensitized rare earth nanoparticles with up/down conversion luminescence for on-demand gas therapy of glioblastoma guided by NIR-II fluorescence imaging. Adv. Healthc. Mater. 2022, 11, 2102042.

Wang, Z. J.; Zhang, M.; Chi, S. Y.; Zhu, M. T.; Wang, C. X.; Liu, Z. H. Brain tumor cell membrane-coated lanthanide-doped nanoparticles for NIR-IIb luminescence imaging and surgical navigation of glioma. Adv. Healthc. Mater. 2022, 11, 2200521.

Li, C. B.; Jiang, G. Y.; Yu, J.; Ji, W. W.; Liu, L. X.; Zhang, P. F.; Du, J.; Zhan, C. L.; Wang, J. G.; Tang, B. Z. Fluorination enhances NIR-II emission and photothermal conversion efficiency of phototheranostic agents for imaging-guided cancer therapy. Adv. Mater. 2023, 35, 2208229.

Zhu, X. L.; Ye, H. Y.; Liu, J. W.; Yu, R. Q.; Jiang, J. H. Multivalent self-assembled DNA polymer for tumor-targeted delivery and live cell imaging of telomerase activity. Anal. Chem. 2018, 90, 13188–13192.

Qi, R. L.; Zhao, H.; Zhou, X.; Liu, J.; Dai, N.; Zeng, Y.; Zhang, E. D.; Lv, F. T.; Huang, Y. M.; Liu, L. B. et al. In situ synthesis of photoactive polymers on a living cell surface via bio-palladium catalysis for modulating biological functions. Angew. Chem., Int. Ed. 2021, 60, 5759–5765.

García-Belda, P.; Prima-García, H.; Aliena-Valero, A.; Castelló-Ruiz, M.; Ulloa-Navas, M. J.; Ten-Esteve, A.; Martí-Bonmatí, L.; Salom, J. B.; García-Verdugo, J. M.; Gil-Perotín, S. Intravenous SPION-labeled adipocyte-derived stem cells targeted to the brain by magnetic attraction in a rat stroke model: An ultrastructural insight into cell fate within the brain. Nanomedicine 2022, 39, 102464.

Huang, Y. P.; Zhang, B. L.; Xie, S. B.; Yang, B. N.; Xu, Q.; Tan, J. Superparamagnetic iron oxide nanoparticles modified with tween 80 pass through the intact blood-brain barrier in rats under magnetic field. ACS Appl. Mater. Interfaces 2016, 8, 11336–11341.

Wu, V. M.; Huynh, E.; Tang, S. A.; Uskoković, V. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles). Acta Biomater. 2019, 88, 422–447.

Li, B. Y.; Chen, X.; Qiu, W.; Zhao, R. R.; Duan, J. Z.; Zhang, S. J.; Pan, Z. W.; Zhao, S. L.; Guo, Q. D.; Qi, Y. H. et al. Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy. Adv. Sci. 2022, 9, e2105451.

Liu, T.; Wang, Y.; Lu, L. J.; Liu, Y. SPIONs mediated magnetic actuation promotes nerve regeneration by inducing and maintaining repair-supportive phenotypes in Schwann cells. J. Nanobiotechnology 2022, 20, 159.

Kanda, T.; Oba, H.; Toyoda, K.; Kitajima, K.; Furui, S. Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn. J. Radiol. 2016, 34, 3–9.

Perlman, O.; Weitz, I. S.; Azhari, H. Copper oxide nanoparticles as contrast agents for MRI and ultrasound dual-modality imaging. Phys. Med. Biol. 2015, 60, 5767–5783.

Shi, H.; Yan, R. Q.; Wu, L. Y.; Sun, Y. D.; Liu, S.; Zhou, Z. Y.; He, J.; Ye, D. J. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis. Acta Biomater. 2018, 72, 256–265.

Li, M.; Wang, Y.; Li, T.; Zhang, J.; Wang, X.; Luo, J.; You, M.; Yang, T.; Deng, Y. B.; Yang, H. et al. Albumin-templated platinum(II) sulfide nanodots for size-dependent cancer theranostics. Acta Biomater. 2023, 155, 564–574.

You, Q.; Zhang, K. Y.; Liu, J. Y.; Liu, C. L.; Wang, H. Y.; Wang, M. T.; Ye, S. Y.; Gao, H. Q.; Lv, L. T.; Wang, C. et al. Persistent regulation of tumor hypoxia microenvironment via a bioinspired Pt-based oxygen nanogenerator for multimodal imaging-guided synergistic phototherapy. Adv. Sci. 2020, 7, 1903341.

Rottenberg, S.; Disler, C.; Perego, P. The rediscovery of platinum-based cancer therapy. Nat. Rev. Cancer 2021, 21, 37–50.

Yu, J.; He, X. D.; Zhang, Q. F.; Zhou, D. F.; Wang, Z. G.; Huang, Y. B. Iodine conjugated Pt(IV) nanoparticles for precise chemotherapy with iodine-pt guided computed tomography imaging and biotin-mediated tumor-targeting. ACS Nano 2022, 16, 6835–6846.

Yang, Y. H.; Guo, L. N.; Wang, Z.; Liu, P.; Liu, X. J.; Ding, J. S.; Zhou, W. H. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. Biomaterials 2021, 264, 120390.

Tang, S. H.; Zheng, J. Antibacterial activity of silver nanoparticles: Structural effects. Adv. Healthc. Mater. 2018, 7, 1701503.

Mansur, A. A. P.; Mansur, H. S.; Carvalho, S. M.; Caires, A. J. One-pot aqueous synthesis of fluorescent Ag-In-Zn-S quantum dot/polymer bioconjugates for multiplex optical bioimaging of glioblastoma cells. Contrast Media Mol. Imaging 2017, 2017, 3896107.

Zhou, X. T.; You, M.; Wang, F. H.; Wang, Z. Z.; Gao, X. F.; Jing, C.; Liu, J. M.; Guo, M. Y.; Li, J. Y.; Luo, A. P. et al. Multifunctional graphdiyne-cerium oxide nanozymes facilitate MicroRNA delivery and attenuate tumor hypoxia for highly efficient radiotherapy of esophageal cancer. Adv. Mater. 2021, 33, 2100556.

Lord, M. S.; Berret, J. F.; Singh, S.; Vinu, A.; Karakoti, A. S. Redox active cerium oxide nanoparticles: Current status and burning issues. Small 2021, 17, 2102342.

Hu, H.; Huang, P.; Weiss, O. J.; Yan, X. F.; Yue, X. Y.; Zhang, M. G.; Tang, Y. X.; Nie, L. M.; Ma, Y.; Niu, G. et al. PET and NIR optical imaging using self-illuminating ⁶⁴Cu-doped chelator-free gold nanoclusters. Biomaterials 2014, 35, 9868–9876.

Zhang, L.; Jiang, C. J.; Li, B.; Liu, Z. W.; Gu, B. X.; He, S. M.; Li, P. L.; Sun, Y.; Song, S. L. A core–shell Au@Cu_2−xSe heterogeneous metal nanocomposite for photoacoustic and computed tomography dual-imaging-guided photothermal boosted chemodynamic therapy. J. Nanobiotechnology 2021, 19, 410.

Chen, L. L.; Zhao, L.; Wang, Z. G.; Liu, S. L.; Pang, D. W. Near-infrared-II quantum dots for in vivo imaging and cancer therapy. Small 2022, 18, 2104567.

Kumar, V. B.; Sher, I.; Rencus-Lazar, S.; Rotenstreich, Y.; Gazit, E. Functional carbon quantum dots for ocular imaging and therapeutic applications. Small 2023, 19, 2205754.

Chung, S.; Revia, R. A.; Zhang, M. Q. Graphene quantum dots and their applications in bioimaging, biosensing, and therapy. Adv. Mater. 2021, 33, 1904362.

Zhang, X. N.; Li, S. S.; Ma, H. Z.; Wang, H.; Zhang, R. P.; Zhang, X. D. Activatable NIR-II organic fluorescent probes for bioimaging. Theranostics 2022, 12, 3345–3371.

Bouzigues, C.; Gacoin, T.; Alexandrou, A. Biological applications of rare-earth based nanoparticles. ACS Nano 2011, 5, 8488–8505.

Li, H.; Wang, X.; Ohulchanskyy, T. Y.; Chen, G. Y. Lanthanide-doped near-infrared nanoparticles for biophotonics. Adv. Mater. 2021, 33, 2000678.

Obermeier, B.; Daneman, R.; Ransohoff, R. M. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 2013, 19, 1584–1596.

Rufino-Ramos, D.; Albuquerque, P. R.; Carmona, V.; Perfeito, R.; Nobre, R. J.; Pereira de Almeida, L. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. J. Control. Release 2017, 262, 247–258.

Kutchy, N. A.; Ma, R.; Liu, Y. T.; Buch, S.; Hu, G. K. Extracellular vesicle-mediated delivery of ultrasmall superparamagnetic iron oxide nanoparticles to mice brain. Front. Pharmacol. 2022, 13, 819516.

Ramalho, M. J.; Loureiro, J. A.; Coelho, M. A. N.; Pereira, M. C. Transferrin receptor-targeted nanocarriers: Overcoming barriers to treat glioblastoma. Pharmaceutics 2022, 14, 279.

Dong, C. Y.; Huang, Q. X.; Cheng, H.; Zheng, D. W.; Hong, S.; Yan, Y.; Niu, M. T.; Xu, J. G.; Zhang, X. Z. Neisseria meningitidis opca protein/MnO₂ hybrid nanoparticles for overcoming the blood-brain barrier to treat glioblastoma. Adv. Mater. 2022, 34, 2109213.

Huang, N.; Cheng, S.; Zhang, X.; Tian, Q.; Pi, J. L.; Tang, J.; Huang, Q.; Wang, F.; Chen, J.; Xie, Z. et al. Efficacy of NGR peptide-modified PEGylated quantum dots for crossing the blood-brain barrier and targeted fluorescence imaging of glioma and tumor vasculature. Nanomedicine 2017, 13, 83–93.

di Polidoro, A. C.; Cafarchio, A.; Vecchione, D.; Donato, P.; De Nola, F.; Torino, E. Revealing angiopep-2/LRP1 molecular interaction for optimal delivery to glioblastoma (GBM). Molecules 2022, 27, 6696.

Xie, R. X.; Wu, Z. J.; Zeng, F. X.; Cai, H. W.; Wang, D.; Gu, L.; Zhu, H. Y.; Lui, S.; Guo, G.; Song, B. et al. Retro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance/fluorescence imaging of glioblastoma. Signal Transduct. Target. Ther. 2021, 6, 309.

Gao, X. H.; Xu, J. L.; Yao, T. T.; Liu, X. X.; Zhang, H. C.; Zhan, C. Y. Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases. Adv. Drug Deliv. Rev. 2022, 187, 114362.

Raja, R.; Rosenberg, G. A.; Caprihan, A. MRI measurements of blood-brain barrier function in dementia: A review of recent studies. Neuropharmacology 2018, 134, 259–271.

Ware, J. B.; Sinha, S.; Morrison, J.; Walter, A. E.; Gugger, J. J.; Schneider, A. L. C.; Dabrowski, C.; Zamore, H.; Wesley, L.; Magdamo, B. et al. Dynamic contrast enhanced MRI for characterization of blood-brain-barrier dysfunction after traumatic brain injury. Neuroimage Clin. 2022, 36, 103236.

Nguyen, G. T.; Coulthard, A.; Wong, A.; Sheikh, N.; Henderson, R.; O’Sullivan, J. D.; Reutens, D. C. Measurement of blood-brain barrier permeability in acute ischemic stroke using standard first-pass perfusion CT data. Neuroimage Clin. 2013, 2, 658–662.

Huang, B.; Tang, T.; Chen, S. H.; Li, H.; Sun, Z. J.; Zhang, Z. L.; Zhang, M. X.; Cui, R. Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury. Nat. Commun. 2023, 14, 197.

Yousaf, T.; Dervenoulas, G.; Politis, M. Advances in MRI methodology. Int. Rev. Neurobiol. 2018, 141, 31–76.

Smits, M. MRI biomarkers in neuro-oncology. Nat. Rev. Neurol. 2021, 17, 486–500.

Krasnovskaya, O.; Spector, D.; Zlobin, A.; Pavlov, K.; Gorelkin, P.; Erofeev, A.; Beloglazkina, E.; Majouga, A. Metals in imaging of Alzheimer’s disease. Int. J. Mol. Sci. 2020, 21, 9790.

Méndez-Gómez, J. L.; Pelletier, A.; Rougier, M. B.; Korobelnik, J. F.; Schweitzer, C.; Delyfer, M. N.; Catheline, G.; Monfermé, S.; Dartigues, J. F.; Delcourt, C. et al. Association of retinal nerve fiber layer thickness with brain alterations in the visual and limbic networks in elderly adults without dementia. JAMA Netw. Open 2018, 1, e184406.

Liu, D. D.; Dai, X. L.; Zhang, W.; Zhu, X. Y.; Zha, Z.; Qian, H. S.; Cheng, L.; Wang, X. W. Liquid exfoliation of ultrasmall zirconium carbide nanodots as a noninflammatory photothermal agent in the treatment of glioma. Biomaterials 2023, 292, 121917.

Liang, S. Y.; Zhou, Q.; Wang, M.; Zhu, Y. H.; Wu, Q. Z.; Yang, X. L. Water-soluble L-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma. Int. J. Nanomedicine 2015, 10, 2325–2333.

Gao, Y.; Wu, C. X.; Chen, X. Q.; Ma, L. L.; Zhang, X.; Chen, J. Z.; Liao, X. H.; Liu, M. PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy. Front. Immunol. 2022, 13, 1049043.

Brighi, C.; Reid, L.; White, A. L.; Genovesi, L. A.; Kojic, M.; Millar, A.; Bruce, Z.; Day, B. W.; Rose, S.; Whittaker, A. K. et al. MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma. Neurooncol. Adv. 2020, 2, vdaa030.

Jiang, Y. Y.; Pu, K. Y. Molecular fluorescence and photoacoustic imaging in the second near-infrared optical window using organic contrast agents. Adv. Biosyst. 2018, 2, e1700262.

Li, C. X.; Wang, Y.; Nong, H. Y.; Hu, X. X.; Wu, Y.; Zhang, Y. J.; Liang, C. M.; Chen, K. G.; Li, S. L. Manganese and dysprosium codoped carbon quantum dots as a potential fluorescent/T1/T2/CT quadri-modal imaging nanoprobe. Nanotechnology 2021, 33, 025101.

Wang, Z. M.; Chen, L. N.; Huang, C. S.; Huang, Y. K.; Jia, N. Q. Albumin-mediated platinum nanocrystals for in vivo enhanced computed tomography imaging. J. Mater. Chem. B 2017, 5, 3498–3510.

Gröhl, J.; Schellenberg, M.; Dreher, K.; Maier-Hein, L. Deep learning for biomedical photoacoustic imaging: A review. Photoacoustics 2021, 22, 100241.

Guo, B.; Sheng, Z. H.; Hu, D. H.; Liu, C. B.; Zheng, H. R.; Liu, B. Through scalp and skull NIR-II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance. Adv. Mater. 2018, 30, 1802591.

Yuan, K. S.; Jurado-Sánchez, B.; Escarpa, A. Nanomaterials meet surface-enhanced Raman scattering towards enhanced clinical diagnosis: A review. J. Nanobiotechnology 2022, 20, 537.

Chen, J.; Sheng, Z. H.; Li, P. H.; Wu, M. X.; Zhang, N. S.; Yu, X. F.; Wang, Y. W.; Hu, D. H.; Zheng, H. R.; Wang, G. P. Indocyanine green-loaded gold nanostars for sensitive SERS imaging and subcellular monitoring of photothermal therapy. Nanoscale 2017, 9, 11888–11901.

Khlebtsov, B.; Burov, A.; Pylaev, T.; Savkina, A.; Prikhozhdenko, E.; Bratashov, D.; Khlebtsov, N. Improving SERS bioimaging of subcutaneous phantom in vivo with optical clearing. J. Biophotonics 2022, 15, e202100281.

Pang, Y. F.; Wang, C. G.; Lu, L. C.; Wang, C. W.; Sun, Z. W.; Xiao, R. Dual-SERS biosensor for one-step detection of microRNAs in exosome and residual plasma of blood samples for diagnosing pancreatic cancer. Biosens. Bioelectron. 2019, 130, 204–213.

Bai, X. R.; Wang, L. H.; Ren, J. Q.; Bai, X. W.; Zeng, L. W.; Shen, A. G.; Hu, J. M. Accurate clinical diagnosis of liver cancer based on simultaneous detection of ternary specific antigens by magnetic induced mixing surface-enhanced Raman scattering emissions. Anal. Chem. 2019, 91, 2955–2963.

Yang, Z. Z.; Du, Y. T.; Sun, Q.; Peng, Y. W.; Wang, R. D.; Zhou, Y.; Wang, Y. Q.; Zhang, C. L.; Qi, X. R. Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma. ACS Nano 2020, 14, 6191–6212.

Gao, D. Y.; Li, Y. X.; Wu, Y. Y.; Liu, Y.; Hu, D. H.; Liang, S. M.; Liao, J. L.; Pan, M.; Zhang, P. F.; Li, K. et al. Albumin-consolidated AIEgens for boosting glioma and cerebrovascular NIR-II fluorescence imaging. ACS Appl. Mater. Interfaces 2023, 15, 3–13.

Zhang, J.; Han, L. L.; Wu, H. G.; Zhong, Y.; Shangguan, P.; Liu, Y. S.; He, M.; Sun, H.; Song, C. H.; Wang, X. et al. A brain-targeting NIR-II ferroptosis system: Effective visualization and oncotherapy for orthotopic glioblastoma. Adv. Sci. 2023, 10, 2206333.

Li, Y.; Gao, J. F.; Wang, S. P.; Du, M. X.; Hou, X. W.; Tian, T.; Qiao, X.; Tian, Z. Q.; Stang, P. J.; Li, S. J. et al. Self-assembled NIR-II fluorophores with ultralong blood circulation for cancer imaging and image-guided surgery. J. Med. Chem. 2022, 65, 2078–2090.

Na, S.; Russin, J. J.; Lin, L.; Yuan, X. Y.; Hu, P.; Jann, K. B.; Yan, L. R.; Maslov, K.; Shi, J. H.; Wang, D. J. et al. Massively parallel functional photoacoustic computed tomography of the human brain. Nat. Biomed. Eng. 2022, 6, 584–592.

Fu, Q. R.; Zhu, R.; Song, J. B.; Yang, H. H.; Chen, X. Y. Photoacoustic imaging: Contrast agents and their biomedical applications. Adv. Mater. 2019, 31, 1805875.

Xia, J. Z.; Feng, G.; Xia, X. R.; Hao, L.; Wang, Z. G. NH₄HCO₃ gas-generating liposomal nanoparticle for photoacoustic imaging in breast cancer. Int. J. Nanomedicine 2017, 12, 1803–1813.

Spedalieri, C.; Kneipp, J. Surface enhanced Raman scattering for probing cellular biochemistry. Nanoscale 2022, 14, 5314–5328.

Andreiuk, B.; Nicolson, F.; Clark, L. M.; Panikkanvalappil, S. R.; Kenry; Rashidian, M.; Harmsen, S.; Kircher, M. F. Design and synthesis of gold nanostars-based SERS nanotags for bioimaging applications. Nanotheranostics 2022, 6, 10–30.

Wang, J.; Ni, D. L.; Bu, W. B.; Zhou, Q.; Fan, W. P.; Wu, Y.; Liu, Y. Y.; Yin, L. K.; Cui, Z. W.; Zhang, X. X. et al. BaHoF₅ nanoprobes as high-performance contrast agents for multi-modal CT imaging of ischemic stroke. Biomaterials 2015, 71, 110–118.

Bloom, G. S. Amyloid-β and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014, 71, 505–508.

Busche, M. A.; Hyman, B. T. Synergy between amyloid-β and Tau in Alzheimer’s disease. Nat. Neurosci. 2020, 23, 1183–1193.

Cisternas, P.; Taylor, X.; Lasagna-Reeves, C. A. The amyloid-tau-neuroinflammation axis in the context of cerebral amyloid angiopathy. Int. J. Mol. Sci. 2019, 20, 6319.

Rai, H.; Gupta, S.; Kumar, S.; Yang, J.; Singh, S. K.; Ran, C. Z.; Modi, G. Near-infrared fluorescent probes as imaging and theranostic modalities for amyloid-beta and tau aggregates in Alzheimer’s disease. J. Med. Chem. 2022, 65, 8550–8595.

Zhou, J.; Jangili, P.; Son, S.; Ji, M. S.; Won, M.; Kim, J. S. Fluorescent diagnostic probes in neurodegenerative diseases. Adv. Mater. 2020, 32, 2001945.

Ossenkoppele, R.; van der Kant, R.; Hansson, O. Tau biomarkers in Alzheimer’s disease: Towards implementation in clinical practice and trials. Lancet Neurol. 2022, 21, 726–734.

Villemagne, V. L.; Doré, V.; Burnham, S. C.; Masters, C. L.; Rowe, C. C. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nat. Rev. Neurol. 2018, 14, 225–236.

Duan, P.; Chen, K. J.; Wijegunawardena, G.; Dregni, A. J.; Wang, H. K.; Wu, H. F.; Hong, M. Binding sites of a positron emission tomography imaging agent in Alzheimer’s β-amyloid fibrils studied using ¹⁹F solid-state NMR. J. Am. Chem. Soc. 2022, 144, 1416–1430.

Miao, J. J.; Wang, L.; Zhu, M. Y.; Xiao, W. W.; Wu, H. J.; Di, M. P.; Huang, Y. Q.; Huang, S. M.; Han, F.; Deng, X. W. et al. Corrigendum to “long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy” [Oral Oncol. 89 (2019) 40-47]. Oral Oncol. 2019, 90, 136.

Surmeier, D. J.; Obeso, J. A.; Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 2017, 18, 101–113.

Liu, J. Y.; Liu, C.; Zhang, J. F.; Zhang, Y. M.; Liu, K. Y.; Song, J. X.; Sreenivasmurthy, S. G.; Wang, Z. Y.; Shi, Y. S.; Chu, C. C. et al. A self-assembled α-synuclein nanoscavenger for Parkinson’s disease. ACS Nano 2020, 14, 1533–1549.

Gao, L. Q.; Wang, W.; Wang, X.; Yang, F.; Xie, L. X.; Shen, J.; Brimble, M. A.; Xiao, Q. C.; Yao, S. Q. Fluorescent probes for bioimaging of potential biomarkers in Parkinson’s disease. Chem. Soc. Rev. 2021, 50, 1219–1250.

Wang, P. Z.; Yu, L.; Gong, J. K.; Xiong, J. H.; Zi, S.; Xie, H.; Zhang, F.; Mao, Z. Q.; Liu, Z. H.; Kim, J. S. An activity-based fluorescent probe for imaging fluctuations of peroxynitrite (ONOO⁻) in the Alzheimer’s disease brain. Angew. Chem., Int. Ed. 2022, 61, e202206894.

An, R. B.; Liu, L. J.; Wei, S. X.; Huang, Z.; Qiu, L.; Lin, J. G.; Liu, H.; Ye, D. J. Controlling disassembly of paramagnetic prodrug and photosensitizer nanoassemblies for on-demand orthotopic glioma theranostics. ACS Nano 2022, 16, 20607–20621.

Andersen, B. M.; Faust Akl, C.; Wheeler, M. A.; Chiocca, E. A.; Reardon, D. A.; Quintana, F. J. Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat. Rev. Cancer 2021, 21, 786–802.

Crivii, C. B.; Boșca, A. B.; Melincovici, C. S.; Constantin, A. M.; Mărginean, M.; Dronca, E.; Suflețel, R.; Gonciar, D.; Bungărdean, M.; Sovrea, A. Glioblastoma microenvironment and cellular interactions. Cancers 2022, 14, 1092.

Martha, S. R.; Fraser, J. F.; Pennypacker, K. R. Acid-base and electrolyte changes drive early pathology in ischemic stroke. Neuromolecular Med. 2019, 21, 540–545.

Cheung, E. C.; Vousden, K. H. The role of ROS in tumour development and progression. Nat. Rev. Cancer 2022, 22, 280–297.

Huang, G. N.; Zang, J. K.; He, L. Z.; Zhu, H. L.; Huang, J. R.; Yuan, Z. W.; Chen, T. F.; Xu, A. D. Bioactive nanoenzyme reverses oxidative damage and endoplasmic reticulum stress in neurons under ischemic stroke. ACS Nano 2022, 16, 431–452.

Moulton, M. J.; Barish, S.; Ralhan, I.; Chang, J. L.; Goodman, L. D.; Harland, J. G.; Marcogliese, P. C.; Johansson, J. O.; Ioannou, M. S.; Bellen, H. J. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease-associated genes. Proc. Natl. Acad. Sci. USA 2021, 118, e2112095118.

Zhou, Y.; Wang, L.; Wang, C. J.; Wu, Y. L.; Chen, D. M.; Lee, T. H. Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas. Arch. Pharm. Res. 2020, 43, 187–203.

Amantea, D.; Marrone, M. C.; Nisticò, R.; Federici, M.; Bagetta, G.; Bernardi, G.; Mercuri, N. B. Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. Int. Rev. Neurobiol. 2009, 85, 363–374.

Wu, Z.; Liu, M. M.; Liu, Z. C.; Tian, Y. Real-time imaging and simultaneous quantification of mitochondrial H₂O₂ and ATP in neurons with a single two-photon fluorescence-lifetime-based probe. J. Am. Chem. Soc. 2020, 142, 7532–7541.

Wang, X.; Li, P.; Ding, Q.; Wu, C. C.; Zhang, W.; Tang, B. Corrigendum: Illuminating the function of the hydroxyl radical in the brains of mice with depression phenotypes by two-photon fluorescence imaging. Angew. Chem., Int. Ed. 2022, 61, e202200503.

Lu, S. C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830, 3143–3153.

Venkateshappa, C.; Harish, G.; Mahadevan, A.; Srinivas Bharath, M. M.; Shankar, S. K. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: Implications for neurodegeneration in Alzheimer’s disease. Neurochem. Res. 2012, 37, 1601–1614.

Aoyama, K. Glutathione in the brain. Int. J. Mol. Sci. 2021, 22, 5010.

von Mässenhausen, A.; Zamora Gonzalez, N.; Maremonti, F.; Belavgeni, A.; Tonnus, W.; Meyer, C.; Beer, K.; Hannani, M. T.; Lau, A.; Peitzsch, M. et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci. Adv. 2022, 8, eabl8920.

Bansal, A.; Simon, M. C. Glutathione metabolism in cancer progression and treatment resistance. J. Cell. Biol. 2018, 217, 2291–2298.

Shi, J. L.; Zuo, H.; Ni, L. C.; Xia, L.; Zhao, L. X.; Gong, M. J.; Nie, D. K.; Gong, P. P.; Cui, D. M.; Shi, W. et al. An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation. Neurol. Sci. 2014, 35, 839–845.

Miao, Y. B.; Chen, K. H.; Chen, C. T.; Mi, F. L.; Lin, Y. J.; Chang, Y.; Chiang, C. S.; Wang, J. T.; Lin, K. J.; Sung, H. W. A noninvasive gut-to-brain oral drug delivery system for treating brain tumors. Adv. Mater. 2021, 33, 2100701.

Zou, Y.; Sun, X. H.; Wang, Y. B.; Yan, C. N.; Liu, Y. J.; Li, J.; Zhang, D. Y.; Zheng, M.; Chung, R. S.; Shi, B. Y. Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment. Adv. Mater. 2020, 32, 2000416.

Cisneros-Mejorado, A.; Pérez-Samartín, A.; Gottlieb, M.; Matute, C. ATP signaling in brain: Release, excitotoxicity and potential therapeutic targets. Cell. Mol. Neurobiol. 2015, 35, 1–6.

Rajendran, M.; Dane, E.; Conley, J.; Tantama, M. Imaging adenosine triphosphate (ATP). Biol. Bull. 2016, 231, 73–84.

Butterfield, D. A.; Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019, 20, 148–160.

Di Virgilio, F.; Sarti, A. C.; Falzoni, S.; De Marchi, E.; Adinolfi, E. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat. Rev. Cancer 2018, 18, 601–618.

Gu, B. J.; Wiley, J. S. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X₇ receptor. Blood 2006, 107, 4946–4953.

Zheng, J. Y.; Li, X. X.; Wang, K.; Song, J. J.; Qi, H. L. Electrochemical nanoaptasensor for continuous monitoring of ATP fluctuation at subcellular level. Anal. Chem. 2020, 92, 10940–10945.

Wang, W.; Li, X.; Tang, K.; Song, Z. L.; Luo, X. L. A AuNP-capped cage fluorescent biosensor based on controlled-release and cyclic enzymatic amplification for ultrasensitive detection of ATP. J. Mater. Chem. B 2020, 8, 5945–5951.

Liu, M.; Walter, G. A.; Pathare, N. C.; Forster, R. E.; Vandenborne, K. A quantitative study of bioenergetics in skeletal muscle lacking carbonic anhydrase III using ³¹P magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA 2007, 104, 371–376.

Sun, P. P.; Chen, H. C.; Lu, S. Y.; Hai, J.; Guo, W. T.; Jing, Y. H.; Wang, B. D. Simultaneous sensing of H₂S and ATP with a two-photon fluorescent probe in Alzheimer’s disease: Toward understanding why H₂S regulates glutamate-induced ATP dysregulation. Anal. Chem. 2022, 94, 11573–11581.

Cheng, Y.; Cheng, A. R.; Jia, Y. L.; Yang, L.; Ning, Y.; Xu, L.; Zhong, Y. Z.; Zhuang, Z. R.; Guan, J. T.; Zhang, X. L. et al. pH-responsive multifunctional theranostic rapamycin-loaded nanoparticles for imaging and treatment of acute ischemic stroke. ACS Appl. Mater. Interfaces 2021, 13, 56909–56922.

Fang, H. X.; Zhang, H.; Li, L.; Ni, Y.; Shi, R. R.; Li, Z.; Yang, X. K.; Ma, B.; Zhang, C. W.; Wu, Q. et al. Rational design of a two-photon fluorogenic probe for visualizing monoamine oxidase A activity in human glioma tissues. Angew. Chem., Int. Ed. 2020, 59, 7536–7541.

Li, N.; Zhang, W. F.; Khan, M.; Lin, L.; Lin, J. M. MoS₂-LA-PEI nanocomposite carrier for real-time imaging of ATP metabolism in glioma stem cells co-cultured with endothelial cells on a microfluidic system. Biosens. Bioelectron. 2018, 99, 142–149.

Peter, S. B.; Nandhan, V. R. 31-Phosphorus magnetic resonance spectroscopy in evaluation of glioma and metastases in 3T MRI. Indian J. Radiol. Imaging 2021, 31, 873–881.

Yan, J. W.; Li, A. Q.; Chen, X. L.; Cao, K. X.; Song, M. C.; Guo, S.; Li, Z.; Huang, S. Q.; Li, Z. L.; Xu, D. H. et al. Glycolysis inhibition ameliorates brain injury after ischemic stroke by promoting the function of myeloid-derived suppressor cells. Pharmacol. Res. 2022, 179, 106208.

McVicar, N.; Li, A. X.; Gonçalves, D. F.; Bellyou, M.; Meakin, S. O.; Prado, M. A.; Bartha, R. Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J. Cereb. Blood Flow Metab. 2014, 34, 690–698.

Zhang, Z. X.; Li, X.; Yang, F.; Chen, C.; Liu, P.; Ren, Y.; Sun, P. K.; Wang, Z. X.; You, Y. P.; Zeng, Y. X. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 2021, 12, 5872.

Wang, Q.; Zhang, C.; Zhu, J. L.; Zhang, L.; Chen, H. R.; Qian, J.; Luo, C. Crucial role of RLIP76 in promoting glycolysis and tumorigenesis by stabilization of HIF-1α in glioma cells under hypoxia. Mol. Neurobiol. 2022, 59, 6724–6739.

Su, R.; Dong, L.; Li, C. Y.; Nachtergaele, S.; Wunderlich, M.; Qing, Y.; Deng, X. L.; Wang, Y. G.; Weng, X. C.; Hu, C. et al. R-2HG exhibits anti-tumor activity by targeting FTO/m⁶A/MYC/CEBPA signaling. Cell 2018, 172, 90–105.e23.

Duan, W. J.; Yue, Q.; Liu, Y.; Zhang, Y. F.; Guo, Q. H.; Wang, C.; Yin, S. J.; Fan, D. D.; Xu, W. J. et al. A pH ratiometrically responsive surface enhanced resonance Raman scattering probe for tumor acidic margin delineation and image-guided surgery. Chem. Sci. 2020, 11, 4397–4402.

Lu, H. W.; Chen, A.; Zhang, X. D.; Wei, Z. X.; Cao, R.; Zhu, Y.; Lu, J. X.; Wang, Z. L.; Tian, L. L. A pH-responsive T₁-T₂ dual-modal MRI contrast agent for cancer imaging. Nat. Commun. 2022, 13, 7948.

Jones, D. N.; Raghanti, M. A. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J. Chem. Neuroanat. 2021, 114, 101957.

Youdim, M. B. H.; Edmondson, D.; Tipton, K. F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 2006, 7, 295–309.

Naoi, M.; Maruyama, W.; Inaba-Hasegawa, K. Type A and B monoamine oxidase in age-related neurodegenerative disorders: Their distinct roles in neuronal death and survival. Curr. Top. Med. Chem. 2012, 12, 2177–2188.

Wang, Y. C.; Wang, X.; Yu, J. J.; Ma, F. Y.; Li, Z.; Zhou, Y.; Zeng, S.; Ma, X. Y.; Li, Y. R.; Neal, A. et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat. Commun. 2021, 12, 3530.

Libert, S.; Pointer, K.; Bell, E. L.; Das, A.; Cohen, D. E.; Asara, J. M.; Kapur, K.; Bergmann, S.; Preisig, M.; Otowa, T. et al. SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 2011, 147, 1459–1472.

Naoi, M.; Maruyama, W.; Shamoto-Nagai, M. Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: From neurotransmitter imbalance to impaired neurogenesis. J. Neural. Transm. 2018, 125, 53–66.

Chun, H.; Lim, J.; Park, K. D.; Lee, C. J. Inhibition of monoamine oxidase B prevents reactive astrogliosis and scar formation in stab wound injury model. Glia 2022, 70, 354–367.

Davis, N.; Mota, B. C.; Stead, L.; Palmer, E. O. C.; Lombardero, L.; Rodríguez-Puertas, R.; de Paola, V.; Barnes, S. J.; Sastre, M. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer’s disease. J. Neuroinflammation 2021, 18, 73.

Tan, Y. Y.; Jenner, P.; Chen, S. D. Monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Past, present, and future. J. Parkinsons Dis. 2022, 12, 477–493.

Kim, D.; Baik, S. H.; Kang, S.; Cho, S. W.; Bae, J.; Cha, M. Y.; Sailor, M. J.; Mook-Jung, I.; Ahn, K. H. Close correlation of monoamine oxidase activity with progress of Alzheimer’s disease in mice, observed by in vivo two-photon imaging. ACS Cent. Sci. 2016, 2, 967–975.

Li, L.; Zhang, C. W.; Ge, J. Y.; Qian, L. H.; Chai, B. H.; Zhu, Q.; Lee, J. S.; Lim, K. L.; Yao, S. Q. A small-molecule probe for selective profiling and imaging of monoamine oxidase B activities in models of Parkinson’s disease. Angew. Chem., Int. Ed. 2015, 54, 10821–10825.

Chan, Z. C. K.; Oentaryo, M. J.; Lee, C. W. MMP-mediated modulation of ECM environment during axonal growth and NMJ development. Neurosci. Lett. 2020, 724, 134822.

Knapinska, A. M.; Fields, G. B. The expanding role of MT1-MMP in cancer progression. Pharmaceuticals 2019, 12, 77.

Wozniak, J.; Floege, J.; Ostendorf, T.; Ludwig, A. Key metalloproteinase-mediated pathways in the kidney. Nat. Rev. Nephrol. 2021, 17, 513–527.

Reinhard, S. M.; Razak, K.; Ethell, I. M. A delicate balance: Role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders. Front. Cell. Neurosci. 2015, 9, 280.

Walz, W.; Cayabyab, F. S. Neutrophil infiltration and matrix metalloproteinase-9 in lacunar infarction. Neurochem. Res. 2017, 42, 2560–2565.

Zheng, X. W.; Zhong, C. K.; Zhu, Z. B.; Zhang, K. X.; Peng, H.; Xu, T.; Bu, X. Q.; Che, B. Z.; Xu, T.; Wang, A. L. et al. Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 209–215.

Rosell, A.; Cuadrado, E.; Ortega-Aznar, A.; Hernandez-Guillamon, M.; Lo, E. H.; Montaner, J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008, 39, 1121–1126.

Huang, Y. M.; Zhang, B. L.; Haneke, H.; Haage, V.; Lubas, M.; Yuan, Y.; Xia, P. F.; Motta, E.; Nanvuma, C.; Dzaye, O. et al. Glial cell line-derived neurotrophic factor increases matrix metallopeptidase 9 and 14 expression in microglia and promotes microglia-mediated glioma progression. J. Neurosci. Res. 2021, 99, 1048–1063.

Ruan, Z. Z.; Zhang, D. D.; Huang, R. X.; Sun, W.; Hou, L. Y.; Zhao, J.; Wang, Q. S. Microglial activation damages dopaminergic neurons through MMP-2/-9-mediated increase of blood-brain barrier permeability in a Parkinson’s disease mouse model. Int. J. Mol. Sci. 2022, 23, 2793.

Rui, X.; Ma, S. X. A retrospective study of probiotics for the treatment of children with antibiotic-associated diarrhea. Medicine 2020, 99, e20631.

Wang, Y. P.; Lin, T. T.; Zhang, W. Y.; Jiang, Y. F.; Jin, H. Y.; He, H. N.; Yang, V. C.; Chen, Y.; Huang, Y. Z. A prodrug-type, MMP-2-targeting nanoprobe for tumor detection and imaging. Theranostics 2015, 5, 787–795.

Cai, Y.; Leng, S.; Ma, Y. Y.; Xu, T. T.; Chang, D.; Ju, S. H. Dynamic change of MMP-9 in diabetic stroke visualized by optical imaging and treated with CD28 superagonist. Biomater. Sci. 2021, 9, 2562–2570.

Cárcel-Márquez, J.; Cullell, N.; Muiño, E.; Gallego-Fabrega, C.; Lledós, M.; Ibañez, L.; Krupinski, J.; Montaner, J.; Cruchaga, C.; Lee, J. M. et al. Causal effect of MMP-1 (matrix metalloproteinase-1), MMP-8, and MMP-12 levels on ischemic stroke: A mendelian randomization study. Stroke 2021, 52, e316–e320.

Chelluboina, B.; Nalamolu, K. R.; Klopfenstein, J. D.; Pinson, D. M.; Wang, D. Z.; Vemuganti, R.; Veeravalli, K. K. MMP-12, a promising therapeutic target for neurological diseases. Mol. Neurobiol. 2018, 55, 1405–1409.

Larochelle, J.; Yang, C. J.; Liu, L.; Candelario-Jalil, E. An unexplored role for MMP-7 (matrix metalloproteinase-7) in promoting gut permeability after ischemic stroke. Stroke 2022, 53, 3238–3242.

Hu, X.; Hai, Z. J.; Wu, C. F.; Zhan, W. J.; Liang, G. L. A Golgi-targeting and dual-color “turn-on” probe for spatially precise imaging of furin. Anal. Chem. 2021, 93, 1636–1642.

Wang, C. C.; Du, W.; Wu, C. F.; Dan, S.; Sun, M.; Zhang, T.; Wang, B.; Yuan, Y.; Liang, G. L. Cathespin B-initiated cypate nanoparticle formation for tumor photoacoustic imaging. Angew. Chem., Int. Ed. 2022, 61, e202114766.

Wang, S.; Shen, H. L.; Mao, Q. L.; Tao, Q.; Yuan, G. T.; Zeng, L. L.; Chen, Z. Y.; Zhang, Y. J.; Cheng, L.; Zhang, J. Z. et al. Macrophage-mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas. ACS Appl. Mater. Interfaces 2021, 13, 56825–56837.

Dallet, L.; Stanicki, D.; Voisin, P.; Miraux, S.; Ribot, E. J. Micron-sized iron oxide particles for both MRI cell tracking and magnetic fluid hyperthermia treatment. Sci. Rep. 2021, 11, 3286.

Tan, J.; Zhou, X. Y.; Zhang, S. Y. Iron-doped cross-linked lipoic acid nano-aggregates for ferroptosis-mediated cancer treatment. Acta Biomater. 2023, 159, 289–299.

Xu, Y. Z.; Liu, S. Y.; Zeng, L. L.; Ma, H. S.; Zhang, Y. F.; Yang, H. H.; Liu, Y. C.; Fang, S.; Zhao, J.; Xu, Y. S. et al. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv. Mater. 2022, 34, 2204733.

Wu, M.; Liu, X. G.; Chen, H.; Duan, Y. K.; Liu, J. J.; Pan, Y. T.; Liu, B. Activation of pyroptosis by membrane-anchoring AIE photosensitizer design: New prospect for photodynamic cancer cell ablation. Angew. Chem., Int. Ed. 2021, 60, 9093–9098.

Chen, Y.; Gao, Y. J.; Chen, Y.; Liu, L.; Mo, A. C.; Peng, Q. Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment. J. Control. Release 2020, 328, 251–262.

Zhi, D. F.; Yang, T.; O’Hagan, J.; Zhang, S. B.; Donnelly, R. F. Photothermal therapy. J. Control. Release 2020, 325, 52–71.

Broadwater, D.; Medeiros, H. C. D.; Lunt, R. R.; Lunt, S. Y. Current advances in photoactive agents for cancer imaging and therapy. Annu. Rev. Biomed. Eng. 2021, 23, 29–60.

Terrazzano, G.; Rubino, V.; Damiano, S.; Sasso, A.; Petrozziello, T.; Ucci, V.; Palatucci, A. T.; Giovazzino, A.; Santillo, M.; De Felice, B. et al. T cell activation induces CuZn superoxide dismutase (SOD)-1 intracellular re-localization, production and secretion. Biochim. Biophys. Acta 2014, 1843, 265–274.

Xu, J. J.; Yu, S.; Wang, X. D.; Qian, Y. Y.; Wu, W. S.; Zhang, S. H.; Zheng, B. B.; Wei, G. G.; Gao, S.; Cao, Z. L. et al. High affinity of chlorin e6 to immunoglobulin G for intraoperative fluorescence image-guided cancer photodynamic and checkpoint blockade therapy. ACS Nano 2019, 13, 10242–10260.

Lv, Z. J.; Jin, L. H.; Gao, W. H.; Cao, Y.; Zhang, H.; Xue, D. Z.; Yin, N.; Zhang, T. Q.; Wang, Y. H.; Zhang, H. J. Novel YOF-based theranostic agents with a cascade effect for NIR-II fluorescence imaging and synergistic starvation/photodynamic therapy of orthotopic gliomas. ACS Appl. Mater. Interfaces 2022, 14, 30523–30532.

Huang, R. Y.; Li, G. Z.; Wang, Z. L.; Hu, H. M.; Zeng, F.; Zhang, K. N.; Wang, K.; Wu, F. Identification of an ATP metabolism-related signature associated with prognosis and immune microenvironment in gliomas. Cancer Sci. 2020, 111, 2325–2335.

Qian, J. W.; Wang, C.; Wang, B.; Yang, J.; Wang, Y. D.; Luo, F. F.; Xu, J. Y.; Zhao, C. J.; Liu, R. H.; Chu, Y. W. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: Hints for glioma anti-PD-1/PD-L1 therapy. J. Neuroinflammation 2018, 15, 290.

Genoud, V.; Marinari, E.; Nikolaev, S. I.; Castle, J. C.; Bukur, V.; Dietrich, P. Y.; Okada, H.; Walker, P. R. Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models. Oncoimmunology 2018, 7, e1501137.

Zhang, J.; Chen, C.; Li, A. N.; Jing, W. Q.; Sun, P.; Huang, X. Y.; Liu, Y. C.; Zhang, S. C.; Du, W.; Zhang, R. et al. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nat. Nanotechnol. 2021, 16, 538–548.

Park, J. H.; Kim, H. J.; Kim, C. W.; Kim, H. C.; Jung, Y.; Lee, H. S.; Lee, Y.; Ju, Y. S.; Oh, J. E.; Park, S. H. et al. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors. Nat. Immunol. 2021, 22, 336–346.

Li, F.; Lv, B. K.; Liu, Y.; Hua, T.; Han, J. B.; Sun, C. M.; Xu, L. M.; Zhang, Z. F.; Feng, Z. M.; Cai, Y. Q. et al. Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells. Oncoimmunology 2018, 7, e1391973.

Macrez, R.; Ali, C.; Toutirais, O.; Le Mauff, B.; Defer, G.; Dirnagl, U.; Vivien, D. Stroke and the immune system: From pathophysiology to new therapeutic strategies. Lancet Neurol. 2011, 10, 471–480.

Li, W.; Yang, J.; Luo, L. H.; Jiang, M. S.; Qin, B.; Yin, H.; Zhu, C. Q.; Yuan, X. L.; Zhang, J. L.; Luo, Z. Y. et al. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat. Commun. 2019, 10, 3349.

Liu, Y.; Chongsathidkiet, P.; Crawford, B. M.; Odion, R.; Dechant, C. A.; Kemeny, H. R.; Cui, X. Y.; Maccarini, P. F.; Lascola, C. D.; Fecci, P. E. et al. Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory. Immunotherapy 2019, 11, 1293–1302.

Yu, M.; Duan, X. H.; Cai, Y. J.; Zhang, F.; Jiang, S. Q.; Han, S. S.; Shen, J.; Shuai, X. T. Multifunctional nanoregulator reshapes immune microenvironment and enhances immune memory for tumor immunotherapy. Adv. Sci. 2019, 6, 1900037.

Abe, C.; Miyazawa, T.; Miyazawa, T. Current use of Fenton reaction in drugs and food. Molecules 2022, 27, 5451.

Zhang, Y. L.; Fu, X.; Jia, J. S.; Wikerholmen, T.; Xi, K. Y.; Kong, Y.; Wang, J. P.; Chen, H. J.; Ma, Y.; Li, Z. W. et al. Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interfaces 2020, 12, 43408–43421.

Wang, X.; Hu, A. D.; Du, K.; Feng, F. D. Biomimetic polymer-templated copper nanoparticles stabilize a temozolomide intermediate for chemotherapy against glioblastoma multiforme. ACS Appl. Bio Mater. 2021, 4, 8004–8012.

Tang, Z. M.; Zhao, P. R.; Wang, H.; Liu, Y. Y.; Bu, W. B. Biomedicine meets Fenton chemistry. Chem. Rev. 2021, 121, 1981–2019.

Li, C. Y.; Wan, Y. L.; Zhang, Y. F.; Fu, L. H.; Blum, N. T.; Cui, R.; Wu, B. D.; Zheng, R.; Lin, J.; Li, Z. M. et al. In situ sprayed starvation/chemodynamic therapeutic gel for post-surgical treatment of IDH1 (R132H) glioma. Adv. Mater. 2022, 34, 2103980.

Chan, M. H.; Li, C. H.; Chang, Y. C.; Hsiao, M. Iron-based ceramic composite nanomaterials for magnetic fluid hyperthermia and drug delivery. Pharmaceutics 2022, 14, 2584.

Chandrasekharan, P.; Tay, Z. W.; Hensley, D.; Zhou, X. Y.; Fung, B. K.; Colson, C.; Lu, Y.; Fellows, B. D.; Huynh, Q.; Saayujya, C. et al. Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: Tracers, hardware, and future medical applications. Theranostics 2020, 10, 2965–2981.

Zhao, L. Y.; Zheng, Y. J.; Yan, H.; Xie, W. S.; Sun, X. D.; Li, N.; Tang, J. T. 2-Deoxy-D-Glucose modified magnetic nanoparticles with dual functional properties: Nanothermotherapy and magnetic resonance imaging. J. Nanosci. Nanotechnol. 2016, 16, 2401–2407.

Zhang, H. M.; Lu, H. Q.; Xiang, L. S.; Bullen, J. W.; Zhang, C. Z.; Samanta, D.; Gilkes, D. M.; He, J. J.; Semenza, G. L. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells. Proc. Natl. Acad. Sci. USA 2015, 112, E6215–E6223.

Ding, X. C.; Wang, L. L.; Zhang, X. D.; Xu, J. L.; Li, P. F.; Liang, H.; Zhang, X. B.; Xie, L.; Zhou, Z. H.; Yang, J. et al. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia. J. Hematol. Oncol. 2021, 14, 92.

Boyd, N. H.; Tran, A. N.; Bernstock, J. D.; Etminan, T.; Jones, A. B.; Gillespie, G. Y.; Friedman, G. K.; Hjelmeland, A. B. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics 2021, 11, 665–683.

Ren, P.; Wang, J. Y.; Zeng, Z. R.; Li, N. X.; Chen, H. L.; Peng, X. G.; Bhawal, U. K.; Guo, W. Z. A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas. Front. Genet. 2022, 13, 976356.

Kaur, B.; Khwaja, F. W.; Severson, E. A.; Matheny, S. L.; Brat, D. J.; Van Meir, E. G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro. Oncol. 2005, 7, 134–153.

Fu, C. P.; Duan, X. H.; Cao, M. H.; Jiang, S. Q.; Ban, X. H.; Guo, N.; Zhang, F.; Mao, J. J.; Huyan, T.; Shen, J. et al. Targeted magnetic resonance imaging and modulation of hypoxia with multifunctional hyaluronic acid-MnO₂ nanoparticles in glioma. Adv. Healthc. Mater. 2019, 8, 1900047.

Jiang, Q.; Geng, X. K.; Warren, J.; Eugene Paul Cosky, E.; Kaura, S.; Stone, C.; Li, F. W.; Ding, Y. C. Hypoxia inducible factor-1α (HIF-1α) mediates NLRP3 inflammasome-dependent-pyroptotic and apoptotic cell death following ischemic stroke. Neuroscience 2020, 448, 126–139.

Tsao, C. C.; Baumann, J.; Huang, S. F.; Kindler, D.; Schroeter, A.; Kachappilly, N.; Gassmann, M.; Rudin, M.; Ogunshola, O. O. Pericyte hypoxia-inducible factor-1 (HIF-1) drives blood-brain barrier disruption and impacts acute ischemic stroke outcome. Angiogenesis 2021, 24, 823–842.

Higashida, T.; Peng, C. Y.; Li, J.; Dornbos III, D.; Teng, K. L.; Li, X. H.; Kinni, H.; Guthikonda, M.; Ding, Y. C. Hypoxia-inducible factor-1α contributes to brain edema after stroke by regulating aquaporins and glycerol distribution in brain. Curr. Neurovasc. Res. 2011, 8, 44–51.

Chen, W. Y.; Chang, M. S. IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J. Immunol. 2009, 182, 5003–5012.

Jakubauskienė, E.; Vilys, L.; Pečiulienė, I.; Kanopka, A. The role of hypoxia on Alzheimer’s disease-related APP and Tau mRNA formation. Gene 2021, 766, 145146.

Sun, X. L.; He, G. Q.; Qing, H.; Zhou, W. H.; Dobie, F.; Cai, F.; Staufenbiel, M.; Huang, L. E.; Song, W. H. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. USA 2006, 103, 18727–18732.

Zhang, F.; Zhong, R. J.; Li, S.; Fu, Z. F.; Cheng, C.; Cai, H. B.; Le, W. D. Acute hypoxia induced an imbalanced M1/M2 activation of microglia through NF-κB signaling in Alzheimer’s disease mice and wild-type littermates. Front. Aging Neurosci. 2017, 9, 282.

Guo, M. Y.; Ji, X. M.; Liu, J. Hypoxia and alpha-synuclein: Inextricable link underlying the pathologic progression of Parkinson’s disease. Front. Aging Neurosci. 2022, 14, 919343.

Wu, X.; Gong, L. J.; Xie, L.; Gu, W. Y.; Wang, X. Y.; Liu, Z. L.; Li, S. Q. NLRP3 deficiency protects against intermittent hypoxia-induced neuroinflammation and mitochondrial ROS by promoting the PINK1-parkin pathway of mitophagy in a murine model of sleep apnea. Front. Immunol. 2021, 12, 628168.

Al-Obaidi, M. M. J.; Desa, M. N. M. Mechanisms of blood brain barrier disruption by different types of bacteria, and bacterial-host interactions facilitate the bacterial pathogen invading the brain. Cell. Mol. Neurobiol. 2018, 38, 1349–1368.

Yau, B.; Hunt, N. H.; Mitchell, A. J.; Too, L. K. Blood-brain barrier pathology and CNS outcomes in Streptococcus pneumoniae meningitis. Int. J. Mol. Sci. 2018, 19, 3555.

Donovan, J.; Figaji, A.; Imran, D.; Phu, N. H.; Rohlwink, U.; Thwaites, G. E. The neurocritical care of tuberculous meningitis. Lancet Neurol. 2019, 18, 771–783.

Gerber, J.; Seitz, R. C.; Bunkowski, S.; Brück, W.; Nau, R. Evidence for frequent focal and diffuse acute axonal injury in human bacterial meningitis. Clin. Neuropathol. 2009, 28, 33–39.

Zhang, X. C.; Zhang, Z. C.; Shu, Q. M.; Xu, C.; Zheng, Q. Q.; Guo, Z.; Wang, Z. X.; Hao, Z. X.; Liu, X.; Wang, G. Q. et al. Copper clusters: An effective antibacterial for eradicating multidrug-resistant bacterial infection in vitro and in vivo. Adv. Funct. Mater. 2021, 31, 2008720.

Meng, X. D.; Sun, S. R.; Gong, C. C.; Yang, J. Y.; Yang, Z.; Zhang, X. J.; Dong, H. F. Ag-doped metal-organic frameworks’ heterostructure for sonodynamic therapy of deep-seated cancer and bacterial infection. ACS Nano 2023, 17, 1174–1186.

Mauro, M.; Crosera, M.; Bovenzi, M.; Adami, G.; Filon, F. L. Pilot study on in vitro silver nanoparticles permeation through meningeal membrane. Colloids Surf. B: Biointerfaces 2016, 146, 245–249.

Rudi, L.; Zinicovscaia, I.; Cepoi, L.; Chiriac, T.; Peshkova, A.; Cepoi, A.; Grozdov, D. Accumulation and effect of silver nanoparticles functionalized with Spirulina platensis on rats. Nanomaterials 2021, 11, 2992.

Mota, F.; Ruiz-Bedoya, C. A.; Tucker, E. W.; Holt, D. P.; De Jesus, P.; Lodge, M. A.; Erice, C.; Chen, X. Y.; Bahr, M.; Flavahan, K. et al. Dynamic ¹⁸F-pretomanid PET imaging in animal models of TB meningitis and human studies. Nat. Commun. 2022, 13, 7974.

Tian, S.; Bai, H. T.; Li, S. L.; Xiao, Y. F.; Cui, X.; Li, X. Z.; Tan, J. H.; Huang, Z. M.; Shen, D.; Liu, W. M. et al. Water-soluble organic nanoparticles with programable intermolecular charge transfer for NIR-II photothermal anti-bacterial therapy. Angew. Chem., Int. Ed. 2021, 60, 11758–11762.

Qin, X.; Zhang, J.; Wang, B.; Xu, G.; Yang, X.; Zou, Z.; Yu, C. Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Autophagy 2021, 17, 4266–4285.

Chen, X.; Kang, R.; Kroemer, G.; Tang, D. L. Broadening horizons: The role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 2021, 18, 280–296.

Lin, L. S.; Song, J. B.; Song, L.; Ke, K. M.; Liu, Y. J.; Zhou, Z. J.; Shen, Z. Y.; Li, J.; Yang, Z.; Tang, W. et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO₂-based nanoagent to enhance chemodynamic therapy. Angew. Chem., Int. Ed. 2018, 57, 4902–4906.

Tsvetkov, P.; Coy, S.; Petrova, B.; Dreishpoon, M.; Verma, A.; Abdusamad, M.; Rossen, J.; Joesch-Cohen, L.; Humeidi, R.; Spangler, R. D. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022, 375, 1254–1261.

Yuan, J. X.; Liu, H. H.; Zhang, H.; Wang, T. T.; Zheng, Q.; Li, Z. Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of Parkinson’s disease. Adv. Mater. 2022, 34, 2108435.

Yu, P.; Zhang, X.; Liu, N.; Tang, L.; Peng, C.; Chen, X. Pyroptosis: Mechanisms and diseases. Signal Transduct. Target. Ther. 2021, 6, 128.

Zheng, P.; Ding, B. B.; Zhu, G. Q.; Li, C. X.; Lin, J. Biodegradable Ca²⁺ nanomodulators activate pyroptosis through mitochondrial Ca²⁺ overload for cancer immunotherapy. Angew. Chem., Int. Ed. 2022, 61, e202204904.

Wang, X. Z.; He, S. S.; Cheng, P. H.; Pu, K. Y. A dual-locked tandem fluorescent probe for imaging of pyroptosis in cancer chemo-immunotherapy. Adv. Mater. 2023, 35, 2206510.

Liu, X. G.; Nie, L. T.; Zhang, Y. L.; Yan, Y. L.; Wang, C.; Colic, M.; Olszewski, K.; Horbath, A.; Chen, X.; Lei, G. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 2023, 25, 404–414.

Koutsaliaris, I. K.; Moschonas, I. C.; Pechlivani, L. M.; Tsouka, A. N.; Tselepis, A. D. Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke. Curr. Med. Chem. 2022, 29, 5496–5509.

Zhu, W. W.; Fang, T.; Zhang, W. J.; Liang, A.; Zhang, H.; Zhang, Z. P.; Zhang, X. E.; Li, F. A ROS scavenging protein nanocage for in vitro and in vivo antioxidant treatment. Nanoscale 2021, 13, 4634–4643.

Bao, Q. Q.; Hu, P.; Xu, Y. Y.; Cheng, T. S.; Wei, C. Y.; Pan, L. M.; Shi, J. L. Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano 2018, 12, 6794–6805.

Zhang, T. F.; Chen, X. Y.; Yuan, C. M.; Pang, X. B.; Shangguan, P.; Liu, Y. S.; Han, L. L.; Sun, J. W.; Lam, J. W. Y.; Liu, Y. et al. Near-infrared aggregation-induced emission luminogens for in vivo theranostics of Alzheimer’s disease. Angew. Chem., Int. Ed. 2023, 62, e202211550.

Edwards III, G.; Zhao, J.; Dash, P. K.; Soto, C.; Moreno-Gonzalez, I. Traumatic brain injury induces tau aggregation and spreading. J. Neurotrauma 2020, 37, 80–92.

Gulani, V.; Calamante, F.; Shellock, F. G.; Kanal, E.; Reeder, S. B. Gadolinium deposition in the brain: Summary of evidence and recommendations. Lancet Neurol. 2017, 16, 564–570.

Funke, S. K. I.; Factor, C.; Rasschaert, M.; Lezius, L.; Sperling, M.; Karst, U.; Robert, P. Long-term gadolinium retention in the healthy rat brain: Comparison between gadopiclenol, gadobutrol, and gadodiamide. Radiology 2022, 305, 179–189.

Mallio, C. A.; Rovira, À.; Parizel, P. M.; Quattrocchi, C. C. Exposure to gadolinium and neurotoxicity: Current status of preclinical and clinical studies. Neuroradiology 2020, 62, 925–934.